RxDoctor Payments DataLook up a doctor →

Gregory Wiener, MD

Gastroenterology · Chula Vista, CANPI 1811099534

Payments from drug & device makers

$3,481,507in general payments, 2019–2025

Across 549 payments — averaging $6341.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Braintree Laboratories, Inc.$1.2M
  • AbbVie$934K
  • Vanda Pharmaceuticals Inc.$646K
  • Ironwood Pharmaceuticals, Inc$423K
  • Takeda Pharmaceuticals U.S.A., Inc.$129K
  • Intercept Pharmaceuticals, Inc.$66K
  • plus $132K from 27 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,481,507 in reported general payments places this provider in the 95th percentile of 1,885 gastroenterology providers in California.

See all gastroenterology providers in California

Medicare billing

Part B allowed, 2024
$106,417
Medicare patients
305
Services billed
816

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gastroenterology in Chula Vista

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →